nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Artificial intelligence and high-dimensional technologies in the theragnosis of systemic lupus erythematosus
|
Yaung, Katherine Nay |
|
|
5 |
3 |
p. e151-e165 |
artikel |
2 |
Assessing glucocorticoid toxicity: are the measures sensitive enough?
|
Robson, Joanna C |
|
|
5 |
3 |
p. e113-e114 |
artikel |
3 |
Correction to Lancet Rheumatol 2022; 4: e163–66
|
|
|
|
5 |
3 |
p. e119 |
artikel |
4 |
Digital Health: An APPlaudable step forward for patients?
|
The Lancet Rheumatology, |
|
|
5 |
3 |
p. e111 |
artikel |
5 |
Glucocorticoid Toxicity Index scores by domain in patients with antineutrophil cytoplasmic antibody-associated vasculitis treated with avacopan versus standard prednisone taper: post-hoc analysis of data from the ADVOCATE trial
|
Patel, Naomi J |
|
|
5 |
3 |
p. e130-e138 |
artikel |
6 |
Livedo reticularis
|
Chatterjee, Soumya |
|
|
5 |
3 |
p. e166 |
artikel |
7 |
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study
|
Qian, Grace |
|
|
5 |
3 |
p. e139-e150 |
artikel |
8 |
Preclinical or subclinical rheumatoid arthritis-associated interstitial lung disease: misleading terms with potentially deleterious consequences
|
Volkmann, Elizabeth R |
|
|
5 |
3 |
p. e116-e118 |
artikel |
9 |
Real-world evidence for prehospital COVID-19 treatment in systemic autoimmune rheumatic disease
|
Bechman, Katie |
|
|
5 |
3 |
p. e114-e115 |
artikel |
10 |
Research in Brief
|
Thorley, Jennifer |
|
|
5 |
3 |
p. e120 |
artikel |
11 |
Temporal trends in adverse pregnancy outcomes in axial spondyloarthritis in Sweden: a cohort study
|
Morin, Matilda |
|
|
5 |
3 |
p. e121-e129 |
artikel |
12 |
TNF inhibitor use during pregnancy in axial spondyloarthritis: are we asking the right questions?
|
Moltó, Anna |
|
|
5 |
3 |
p. e112-e113 |
artikel |